• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
?
-

Resources for You

FDA Webinar: Webinar Draft GFI on Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment; Availability - July 25, 2013

On July 25, 2013, FDA presented a webinar on a new draft guidance entitled "Draft Guidance for Industry on Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment; Availability."

 
The webinar provided an opportunity to learn about the guidance from individuals involved in its preparation. It was also intended to encourage the submission of questions or comments while the guidance is still in draft form.
 
Questions may be submitted to docket so that they can be formally processed by FDA.
 
DRAFT GFI:
 
FR NOTICE
 
Date FR NOA: 06/05/2013
Comment Period Closes: 08/09/2013
 
CONTACT:
Jeffrey Murray, MD, MPH
Deputy Director
Division of Antiviral Products
Office of Antimicrobial Products
Center for Drug Evaluation and Research (CDER)
WO, Bldg 22, Room 6370
301-796-1500
Archive of Past Webinars: http://www.fda.gov/Training/GuidanceWebinars/default.htm   
 
If you have never attended a Connect Pro meeting before, please test your connection before the lecture by following this link: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm